Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
www.ahrq.gov

Table 177
Percent of patients with adverse drug events: anticoagulant-related low-molecular-weight heparin and Factor Xa, United States, 2005a
Population group Percent SE
Total   6.98 0.35
Age Under 65 6.60 0.93
65-74 6.51 0.59
75-84 7.37 0.60
85 and over 7.37 0.85
Gender Female 7.13 0.46
Male 7.19 0.55
Race White 6.82 0.37
Black 6.48 1.09
Other 10.94 1.95
Diabetes Yes 7.42 0.62
No 6.76 0.42
Obesity Yes 7.69 0.94
No 6.86 0.38
Cerebrovascular disease Yes 8.08 0.76
No 6.63 0.39
CHF/pulmonary edema Yes 7.89 0.62
No 6.49 0.42
COPD Yes 7.28 0.60
No 6.82 0.43
Smoking Yes 6.88 0.89
No 7.00 0.38
Corticosteroids Yes 7.55 1.21
No 6.93 0.37
Coronary artery disease Yes 8.37 0.55
No 5.73 0.44
Renal disease Yes 11.93 0.89
No 5.31 0.36

a Data include Medicare beneficiaries discharged from January to December.

Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.

 
AHRQ Advancing Excellence in Health Care